| ²é¿´: 516 | »Ø¸´: 5 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
[½»Á÷]
ÇóÖú·ÒëÒ»¶Î»° лл
|
|||
| Hybridoma cell lines have been generated which produce and secrete monoclonal antibodies which selectively bind to tilmicosin. These hybridomas may be obtained by using as an immunization agent or immunogen, 23-deoxo-23-demycinosyl tilmicosin which has been conjugated to an immunogenic carrier. The antibodies may be used to detect and/or quantify tilmicosin in biological samples. The monoclonal antibodies also may be incorporated into kits. |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
¿¼ÑÐÉúÎïѧ¿¼AÇø211£¬³õÊÔ322£¬¿ÆÄ¿Éú»¯ºÍÉúÎï×ۺϣ¬Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
¹¤¿Æ277·ÖÇóµ÷¼Á²ÄÁÏ
ÒѾÓÐ9È˻ظ´
085602µ÷¼Á ³õÊÔ×Ü·Ö335
ÒѾÓÐ6È˻ظ´
µ÷¼Á
ÒѾÓÐ3È˻ظ´
315Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
298·Ö 070300Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
2Â¥2009-08-12 11:09:33
![]() ![]() ![]() |
3Â¥2009-08-12 11:13:59
![]() |
4Â¥2009-08-12 13:24:11
kongxiangshi
½ð³æ (СÓÐÃûÆø)
- ·ÒëEPI: 2
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1255.5
- Ìû×Ó: 120
- ÔÚÏß: 18.8Сʱ
- ³æºÅ: 431935
- ×¢²á: 2007-08-12
- ÐÔ±ð: GG
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
ÎÒÊÇѧÉúÎïµÄ£¬ÎÒÀ´ÁË
¡ï ¡ï ¡ï ¡ï ¡ï
fangmingfeng(½ð±Ò+1,VIP+0):лл 8-12 21:29
fangmingfeng(½ð±Ò+4,VIP+0): 8-12 21:32
fangmingfeng(½ð±Ò+1,VIP+0):лл 8-12 21:29
fangmingfeng(½ð±Ò+4,VIP+0): 8-12 21:32
|
ÔÓ½»Áöϸ°ûÖêÒѾ²úÉú£¬ÕâÖÖÔÓ½»Áöϸ°û¿ÉÒÔÉú²úºÍ·ÖÃÚÑ¡ÔñÐÔ½áºÏÌæÃ׿¼ÐÇ(¿¹¾úÒ©)µÄµ¥¿Ë¡¿¹Ìå¡£ÕâÖÖÔÓ½»Áöϸ°û¿ÉÒÔͨ¹ýʹÓÃÃâÒßÊÔ¼Á»òÕßÃâÒßÔ£¬Ò²¾ÍÊÇÒѽáºÏ23 deoxo - 23 - demycinosylÌæÃ׿¼ÐǵÄÃâÒßÔÔØÌåÀ´»ñµÃ¡£¸Ã¿¹Ìå¿ÉÓÃÓÚ¶¨ÐÔ¼ì²âºÍ/»ò¶¨Á¿²â¶¨ÉúÎïÑùÆ·ÖÐÌæÃ׿¼Ðǵĺ¬Á¿¡£»¹¿ÉÒ԰ѵ¥¿Ë¡¿¹Ìå½áºÏµ½ÄÒÖС£ ÐÖµÜÕâ¸ö¡°23 deoxo - 23 - demycinosyl¡±£¬ÎÒʵÔÚÊÇ·Òë²»³öÀ´£¬ÄãµÃÇëѧ»¯Ñ§µÄ¸ßÊÖÁË¡£ |
5Â¥2009-08-12 14:59:49
wangkt
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2416
- É¢½ð: 40
- ºì»¨: 2
- Ìû×Ó: 905
- ÔÚÏß: 115.2Сʱ
- ³æºÅ: 689100
- ×¢²á: 2009-01-07
- ÐÔ±ð: MM
- רҵ: ÉúÎïÎÞ»ú»¯Ñ§
¡ï ¡ï ¡ï ¡ï ¡ï
fangmingfeng(½ð±Ò+1,VIP+0):±§Ç¸ 8-12 21:30
fangmingfeng(½ð±Ò+4,VIP+0): 8-12 21:32
fangmingfeng(½ð±Ò+1,VIP+0):±§Ç¸ 8-12 21:30
fangmingfeng(½ð±Ò+4,VIP+0): 8-12 21:32
|
Hybridoma cell lines have been generated which produce and secrete monoclonal antibodies which selectively bind to tilmicosin. These hybridomas may be obtained by using as an immunization agent or immunogen, 23-deoxo-23-demycinosyl tilmicosin which has been conjugated to an immunogenic carrier. The antibodies may be used to detect and/or quantify tilmicosin in biological samples. The monoclonal antibodies also may be incorporated into kits. Äܹ»²úÉúºÍÒþ²Øµ¥¿Ë¡ÌåµÄÔÓϸ°ûȺÒѾ²úÉú£¬ËüµÄÑ¡ÔñÐÔºÍÌæÃ׿¼Ð£¨¿¹¾úÒ©£©Óйء£ÕâЩÔÓϸ°û¿ÉÄÜÀûÓÃÒ»¸öÃâÒßϵͳ»ò×÷ÓüÁµÃµ½£¬23-deoxo-23-demycinosyl ÌæÃ׿¼ÐÂÒѾÔÚ²úÉúÃâÒßÐÔµÄÔ˶¯ÖÐÐγɹ²éî¡£¿¹ÌåÒ²Ðíϰ¹ßÓÚÓÃÓÚ·¢ÏÖ»òÈ·¶¨ÉúÎïÑù±¾ÖеÄÌæÃ׿¼ÐÂÊýÁ¿¡£µ¥¿Ë¡ÌåÒ²ÐíÒ²³ÉΪÁËÅäÌåµ¥ÔªµÄÒ»²¿·Ö¡£ £¨±§Ç¸×¨ÒµÊõÓï·²»ºÃ£© |
6Â¥2009-08-12 15:00:52














»Ø¸´´ËÂ¥

10